off brand glp 1 Ozempic, Wegovy, Zepbound — and off-brand copies sold online — have revolutionized the weight-loss industry because they are remarkably effective in suppressing appetite. But in addition to the better-known risks of gastrointestinal GLP-1 Drugs: 6 Things We've

GLP-1 telehealth platforms and celebrity-fronted campaigns have already shown what happens when the pendulum swings too far toward hype: aggressive before-and-after narratives, casual talk of microdosing, and very little discussion of who should not be on these medications or what long-term adherence realistically looks like

The impact of MASLD on long-term hepatic outcomes, such as liver fibrosis and HCC in co-infection with hepatitis B virus, is controversial and may depend on disease severity and the presence of metabolic syndrome

Press release: Novo Nordisk files for FDA approval of a higher dose of Wegovy injection 7.2 mg

If Im using a tool, I need to know exactly what that tool is. Inaccurate dosing Varied potency Potential contamination Use of ingredients (such as semaglutide sodium) that were not evaluated in clinical trials Lack of long-term safety data If you are creating your own dosage, rather than following what your doctor prescribes, you also face risks

For branded medications like Zepbound, patients would need to manage insurance coverage separately outside the Fella Health platform